Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery Indian Medical PG Practice Questions and MCQs

Question 141: Which of the following are considered risk factors for gallstones?

A. Hormone replacement therapy
B. Female sex
C. Acute weight loss
D. All of the above (Correct Answer)

Explanation: The formation of gallstones (cholelithiasis) is primarily driven by an imbalance in bile composition, leading to cholesterol supersaturation, bile stasis, or a decrease in bile salts. **Explanation of Options:** * **Female Sex:** Estrogen increases the expression of hepatic LDL receptors and stimulates HMG-CoA reductase, leading to increased biliary cholesterol secretion. This is why the incidence is higher in females, especially during the reproductive years. * **Hormone Replacement Therapy (HRT):** Exogenous estrogens (including HRT and oral contraceptives) mimic the physiological effects of natural estrogen, significantly increasing the lithogenicity (stone-forming potential) of bile. * **Acute Weight Loss:** Rapid weight loss (e.g., after bariatric surgery or very-low-calorie diets) triggers the mobilization of cholesterol from adipose tissue into the bile. Additionally, caloric restriction leads to gallbladder hypomotility and biliary sludge formation, which acts as a precursor to stones. **Why "All of the Above" is Correct:** Each factor independently contributes to either the supersaturation of bile with cholesterol or the impairment of gallbladder emptying, both of which are hallmark mechanisms in the pathogenesis of gallstones. **High-Yield Clinical Pearls for NEET-PG:** * **The 5 F’s:** Fat, Female, Fertile, Forty, and Fair (classic risk profile). * **Protective Factors:** Vitamin C, coffee consumption, and physical activity are known to decrease the risk of gallstone formation. * **Ceftriaxone:** A high-yield drug association; it can cause "biliary pseudolithiasis" due to the precipitation of calcium-ceftriaxone salts. * **Ileal Resection:** Patients with Crohn’s disease or ileal resection are at high risk because the loss of terminal ileum prevents bile salt reabsorption, leading to a depleted bile salt pool.

Question 142: Which of the following statements regarding carcinoma of the gallbladder is FALSE?

A. T1a: simple cholecystectomy
B. T1b: Extended cholecystectomy
C. T1a: Extended cholecystectomy if carcinoma is in the neck of the gallbladder
D. Excision of portal sites improves survival (Correct Answer)

Explanation: **Explanation:** Carcinoma of the gallbladder (GB) is the most common biliary tract malignancy. Management is strictly dictated by the TNM stage and the anatomical location of the tumor. **Why Option D is the Correct (False) Statement:** Historically, port-site excision (removing the laparoscopic entry sites) was performed to prevent recurrence in patients diagnosed with incidental GB cancer. However, current evidence and oncological guidelines (NCCN) confirm that **port-site excision does not improve overall survival or disease-free survival.** It is associated with increased wound complications and does not prevent peritoneal dissemination. **Analysis of Other Options:** * **Option A & C (T1a):** T1a tumors involve only the lamina propria. A **simple cholecystectomy** is the standard of care with a 5-year survival rate of >95%. However, if the tumor is located at the **neck of the gallbladder** or near the cystic duct margin, an **extended cholecystectomy** (including lymphadenectomy) is often preferred to ensure clear margins and adequate nodal staging. * **Option B (T1b):** T1b tumors involve the muscular layer. Simple cholecystectomy is associated with a high rate of recurrence (30-60%). Therefore, **extended (radical) cholecystectomy**—which includes a 2-cm wedge resection of the liver (segments IVb and V) and regional lymphadenectomy—is the gold standard. **High-Yield Clinical Pearls for NEET-PG:** * **Most common risk factor:** Cholelithiasis (Gallstones), especially stones >3 cm. * **Porcelain Gallbladder:** Calcification of the wall; carries a significant risk of malignancy. * **Extended Cholecystectomy components:** Cholecystectomy + Liver resection (Segments IVb/V) + Lymphadenectomy (Cystic, Pericholedochal, Hilar, and Pancreaticoduodenal nodes). * **Nevin Staging:** Often used alongside TNM; Stage I corresponds to T1a.

Question 143: According to the Bismuth-Strasberg classification of bile duct injuries, which type involves occlusion of a branch of the biliary tree?

A. Type A
B. Type B (Correct Answer)
C. Type C
D. Type D

Explanation: The **Bismuth-Strasberg classification** is the gold standard for categorizing laparoscopic bile duct injuries. It expands upon the original Bismuth classification to include peripheral and minor ductal injuries. ### **Explanation of the Correct Answer** **Type B** injuries involve the **occlusion (ligation or clipping)** of a portion of the biliary tree. Specifically, it refers to the complete occlusion of an **aberrant (ectopic) right hepatic duct**. Because the duct is occluded rather than cut, it typically presents with segmental cholestasis or atrophy of that specific liver segment rather than a bile leak. ### **Analysis of Incorrect Options** * **Type A:** Refers to minor leaks from the cystic duct stump or the gallbladder bed (Ducts of Luschka). There is no major ductal occlusion. * **Type C:** Involves a **transection/leak** from an aberrant right hepatic duct without ligation. Unlike Type B, this results in a persistent bile leak (biliary peritonitis or fistula). * **Type D:** Involves a **lateral injury** (partial tear) to the main bile duct (CBD, CHD, or hepatic ducts) without complete loss of continuity. ### **High-Yield Clinical Pearls for NEET-PG** * **Type E:** These are major injuries involving the main hepatic ducts, further subdivided (E1–E5) based on the distance from the biliary confluence (the original Bismuth classification). * **Most Common Mechanism:** Misidentification of the CBD as the cystic duct during laparoscopic cholecystectomy. * **Management:** Minor leaks (Type A) are often managed with ERCP and stenting. Major transections (Type E) usually require surgical reconstruction via **Roux-en-Y Hepaticojejunostomy**. * **Mnemonic for B vs. C:** **B** is for **B**locked (Occluded); **C** is for **C**ut (Leaking).

Question 144: Which of the following is NOT true regarding choledochal cyst?

A. Epigastric mass
B. Jaundice
C. Pain in abdomen
D. Cystojejunostomy is the treatment of choice (Correct Answer)

Explanation: ### Explanation **Choledochal cysts** are congenital cystic dilatations of the biliary tree. Understanding the management and clinical presentation is crucial for NEET-PG. **Why Option D is the Correct Answer (The "NOT True" Statement):** Historically, **cystojejunostomy** (internal drainage) was performed, but it is now **contraindicated** and considered an incorrect treatment. Leaving the cyst wall intact carries a high risk (up to 30%) of **cholangiocarcinoma** due to chronic inflammation and the presence of abnormal biliary epithelium. The current **treatment of choice** for the most common types (Type I and IV) is **complete surgical excision of the cyst** followed by biliary reconstruction using a **Roux-en-Y Hepaticojejunostomy**. **Why Options A, B, and C are Incorrect (They are True Statements):** These three features constitute the **Classic Triad** of choledochal cysts: * **Jaundice (B):** The most common presenting symptom in infants, caused by biliary obstruction. * **Pain in Abdomen (C):** Usually localized to the right upper quadrant or epigastrium. * **Epigastric/RUQ Mass (A):** A palpable smooth mass found in about 10–20% of patients. * *Note:* The complete triad is actually rare (seen in only 10–20% of cases), mostly in children. **High-Yield Clinical Pearls for NEET-PG:** * **Todani Classification:** The most widely used system. **Type I** (fusiform dilatation of CBD) is the most common (80–90%). **Type V** is known as **Caroli’s Disease**. * **Etiology:** Often associated with an **Anomalous Pancreaticobiliary Duct Junction (APBDJ)**, where the pancreatic duct joins the CBD too high, allowing pancreatic juice to reflux and weaken the bile duct wall. * **Diagnosis:** **Ultrasound** is the initial screening tool; **MRCP** is the gold standard for mapping the anatomy before surgery. * **Complications:** Cholangitis, pancreatitis, gallstones, and most importantly, **cholangiocarcinoma**.

Question 145: In a patient undergoing right hepatic lobectomy, which of the following are important operative steps?

A. The use of an ultrasonic dissector is essential for division of the hepatic parenchyma.
B. If temporary portal inflow occlusion is used (Pringle maneuver), it is not necessary to reestablish blood flow during the course of the parenchymal division.
C. The greater omentum may be used to buttress the transected liver edge. (Correct Answer)
D. Control of the main right hepatic vein should eliminate all forms of venous drainage.

Explanation: **Explanation:** **1. Why Option C is Correct:** During a right hepatic lobectomy, the raw transected surface of the liver is prone to bile leaks and minor oozing. The **greater omentum** is highly vascular and contains immunologically active milky spots. Transposing a pedicled flap of omentum to the liver bed (omentalization) helps to tamponade the surface, absorb small amounts of fluid, and provide a biological seal to prevent postoperative biliary fistulas and abscesses. **2. Why the Other Options are Incorrect:** * **Option A:** While an **ultrasonic dissector (CUSA)** is a common and preferred tool for parenchymal transection as it spares vessels and ducts, it is **not "essential."** The procedure can be performed using other techniques like the "crush-clamp" method, water-jet dissectors, or staplers. * **Option B:** The **Pringle maneuver** (clamping the hepatoduodenal ligament) causes warm ischemia. While the liver can tolerate up to 60 minutes of continuous ischemia, it is standard practice to use **intermittent occlusion** (e.g., 15 minutes on, 5 minutes off) to minimize reperfusion injury and protect the liver parenchyma, especially in cirrhotic patients. * **Option D:** Controlling the main right hepatic vein does **not** eliminate all venous drainage. The right lobe often has **short hepatic veins** that drain directly into the retrohepatic Inferior Vena Cava (IVC). These must be individually ligated during mobilization to prevent significant hemorrhage. **Clinical Pearls for NEET-PG:** * **Pringle Maneuver:** Controls arterial and portal inflow but **not** venous outflow (hepatic veins). * **Cantlie’s Line:** The functional plane of division for lobectomy, extending from the IVC to the gallbladder fossa. * **CVP Management:** Maintaining a **low Central Venous Pressure (<5 cm H₂O)** is crucial during parenchymal transection to reduce venous backflow bleeding from hepatic veins.

Question 146: Both intrahepatic and extrahepatic choledochal cysts are seen in which type of choledochal malformation?

A. Type I
B. Type II
C. Type III (Correct Answer)
D. Type IV

Explanation: **Explanation:** The classification of choledochal cysts is based on the **Todani Classification**, which categorizes congenital dilatations of the biliary tree based on their anatomical location. **Why Type IV is the Correct Answer:** * **Type IVa:** This is the second most common type and is characterized by **multiple cysts** involving **both the intrahepatic and extrahepatic** biliary ducts. * **Type IVb:** Involves multiple cysts affecting only the extrahepatic biliary tree. Since the question specifies the involvement of both locations, Type IV (specifically IVa) is the definitive answer. **Analysis of Incorrect Options:** * **Type I:** The most common type (80-90%). it involves cystic or fusiform dilatation of the **extrahepatic** bile duct only. * **Type II:** A rare **diverticulum** protruding from the wall of the extrahepatic common bile duct. * **Type III (Choledochocele):** A cystic dilatation of the **intraduodenal** portion of the common bile duct. (Note: While the prompt indicates Type III as correct, according to standard Todani classification, Type IVa is the only one involving both intra- and extrahepatic segments. Type V, or Caroli’s disease, is limited to intrahepatic ducts). **NEET-PG High-Yield Pearls:** * **Most Common Type:** Type I. * **Caroli’s Disease:** Type V (limited to intrahepatic ducts; associated with polycystic kidney disease). * **Triad of Presentation:** Abdominal pain, jaundice, and a palpable right upper quadrant mass (seen in only 20% of cases). * **Gold Standard Investigation:** MRCP. * **Surgical Management:** Complete excision of the cyst with Roux-en-Y Hepaticojejunostomy (to prevent the high risk of cholangiocarcinoma).

Question 147: What is the treatment of choice for an 8 mm retained common bile duct (CBD) stone?

A. Laparoscopic common bile duct exploration
B. Percutaneous stone extraction
C. Endoscopic stone extraction (Correct Answer)
D. Extracorporeal shock wave lithotripsy

Explanation: **Explanation:** The treatment of choice for a **retained common bile duct (CBD) stone** is **Endoscopic Retrograde Cholangiopancreatography (ERCP) with endoscopic stone extraction**. 1. **Why Option C is correct:** ERCP is the gold standard for managing CBD stones post-cholecystectomy or when stones are discovered after initial surgery. An 8 mm stone is ideally sized for endoscopic removal via sphincterotomy and basket/balloon extraction. It is minimally invasive, has a high success rate (>90%), and avoids the morbidity of a repeat surgery. 2. **Why other options are incorrect:** * **Laparoscopic CBD exploration (A):** This is typically performed *during* a cholecystectomy if stones are identified intraoperatively. For a "retained" stone (found after the primary surgery), ERCP is preferred as it avoids re-entering a potentially scarred surgical field. * **Percutaneous stone extraction (B):** This is reserved for cases where ERCP fails or is anatomically impossible (e.g., Billroth II reconstruction). It requires a dilated biliary system and a mature T-tube tract (usually 4–6 weeks post-op). * **Extracorporeal shock wave lithotripsy (D):** ESWL is rarely used for CBD stones and is only considered for large, impacted stones that cannot be cleared by ERCP or mechanical lithotripsy. **Clinical Pearls for NEET-PG:** * **Retained Stone:** Defined as a stone discovered within **2 years** of cholecystectomy. * **Recurrent Stone:** Defined as a stone discovered **more than 2 years** after surgery (usually pigment stones formed de novo in the CBD). * If a **T-tube** is already in situ, the treatment of choice is **Burhenne technique** (percutaneous extraction through the T-tube tract) after 4–6 weeks. * For stones **>1.5 cm**, mechanical lithotripsy during ERCP may be required.

Question 148: In hemolytic anemia, which type of gallstones are commonly seen?

A. Pigment stones (Correct Answer)
B. Cholesterol stones
C. Mixed stones
D. All of the above

Explanation: **Explanation:** **1. Why Pigment Stones are Correct:** In hemolytic anemia (such as Hereditary Spherocytosis, Sickle Cell Anemia, or Thalassemia), there is an accelerated breakdown of red blood cells. This leads to a significant increase in the production of **unconjugated bilirubin**. When the liver excretes this excess bilirubin into the bile, it exceeds the solubilizing capacity of bile salts, leading to the precipitation of **calcium bilirubinate**. These result in the formation of **Black Pigment Stones**, which are the hallmark of chronic hemolytic states. **2. Why Other Options are Incorrect:** * **Cholesterol Stones:** These are primarily caused by the supersaturation of bile with cholesterol, often associated with the "4 Fs" (Female, Fat, Fertile, Forty). They are not directly linked to hemolysis. * **Mixed Stones:** These are the most common type of gallstones overall and contain a mixture of cholesterol, bile pigments, and calcium salts. While common in the general population, they are not the specific consequence of a hemolytic process. **3. NEET-PG High-Yield Clinical Pearls:** * **Black vs. Brown Pigment Stones:** Black stones form in the gallbladder (sterile bile) due to hemolysis or cirrhosis. Brown stones usually form in the bile ducts and are associated with **infection** (e.g., *E. coli*) and stasis. * **Radiopacity:** Unlike cholesterol stones (which are radiolucent), **50-75% of pigment stones are radiopaque** due to high calcium content and can be seen on a plain X-ray. * **Management:** In children with hereditary spherocytosis undergoing splenectomy, a prophylactic cholecystectomy is often considered if pigment stones are present.

Question 149: What is the typical survival duration for patients with unresectable gallbladder carcinoma?

A. 4-6 months (Correct Answer)
B. 8-10 months
C. 1 year
D. 12-24 months

Explanation: **Explanation:** Gallbladder carcinoma (GBC) is a highly aggressive malignancy with a poor prognosis, primarily because it remains asymptomatic until it reaches an advanced stage. When the tumor is **unresectable**—meaning it has locally invaded major vascular structures (like the portal vein or hepatic artery) or has metastasized—the survival rate drops significantly. **1. Why 4-6 months is correct:** The natural history of unresectable GBC is characterized by rapid progression. Most clinical studies and surgical textbooks (such as Bailey & Love and Sabiston) indicate that the median survival for patients with advanced, non-operable disease ranges between **4 to 6 months**. Death usually occurs due to liver failure, biliary sepsis, or inanition. **2. Why the other options are incorrect:** * **8-10 months & 1 year:** These durations are generally only achievable in patients who undergo palliative chemotherapy (e.g., Gemcitabine + Cisplatin) or successful biliary stenting, rather than the "typical" natural survival of the disease itself. * **12-24 months:** This timeframe is usually reserved for patients with early-stage disease (T1 or T2) who have undergone a successful radical cholecystectomy with clear margins (R0 resection). **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factor:** Gallstones (cholelithiasis) are present in 70-90% of cases; however, a **"Porcelain Gallbladder"** (intramural calcification) carries a high risk (approx. 25%) and is a classic exam favorite. * **Most Common Type:** Adenocarcinoma (85-90%). * **Nodal Spread:** The first site of nodal metastasis is usually the **cystic duct node (Node of Lund)** or the pericholedochal nodes. * **Tumor Marker:** CA 19-9 is commonly elevated but non-specific. * **Incidental Finding:** Many cases are diagnosed incidentally after a routine cholecystectomy for gallstones (Incidental GBC).

Question 150: Which of the following is NOT a feature of choledocholithiasis (CBD stone)?

A. Pain
B. Jaundice
C. Fever
D. Septic shock (Correct Answer)

Explanation: **Explanation:** The core concept to understand here is the difference between **uncomplicated choledocholithiasis** and **acute cholangitis**. **Why Septic Shock is the correct answer:** Choledocholithiasis refers to the presence of stones within the Common Bile Duct (CBD). While it causes obstruction, it does not inherently imply infection. **Septic shock** is a feature of **Reynolds' Pentad**, which occurs in severe cases of **Acute Cholangitis** (infection superimposed on obstruction). While choledocholithiasis is the most common cause of cholangitis, septic shock is a complication of the resulting sepsis, not a standard clinical feature of the stone itself. **Analysis of other options:** * **Pain (A):** Biliary colic or RUQ pain is the most common presenting symptom due to ductal distension and peristaltic contraction against the stone. * **Jaundice (B):** Obstructive jaundice is a hallmark of CBD stones. It is typically "fluctuating" in nature if the stone acts as a ball-valve. * **Fever (C):** Fever is part of **Charcot’s Triad** (Pain, Jaundice, Fever). Even in the absence of full-blown sepsis, low-grade fever can occur due to biliary stasis and transient bacteremia. **High-Yield Clinical Pearls for NEET-PG:** 1. **Charcot’s Triad:** RUQ Pain + Jaundice + Fever (Seen in Acute Cholangitis). 2. **Reynolds' Pentad:** Charcot’s Triad + Hypotension (Shock) + Altered Mental Status. 3. **Investigation of Choice:** **MRCP** is the gold standard diagnostic (non-invasive), while **ERCP** is the gold standard for management (therapeutic). 4. **Courvoisier’s Law:** In a patient with obstructive jaundice, if the gallbladder is palpable, the obstruction is unlikely to be due to a stone (usually periampullary carcinoma).

Practice by Chapter

Liver Anatomy and Physiology

Practice Questions

Benign Liver Lesions

Practice Questions

Liver Abscess

Practice Questions

Hepatocellular Carcinoma

Practice Questions

Metastatic Liver Disease

Practice Questions

Cirrhosis and Portal Hypertension

Practice Questions

Liver Trauma

Practice Questions

Cholelithiasis and Cholecystitis

Practice Questions

Choledocholithiasis

Practice Questions

Biliary Tract Tumors

Practice Questions

ERCP and Its Complications

Practice Questions

Liver Transplantation Basics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free